Related Experiment Video
Updated: Mar 12, 2026
Cholesterol Efflux Assay
Published on: March 6, 2012
Cohort study investigating the relationship between cholesterol, cardiovascular risk score and the prescribing of
Samuel Finnikin1, Ronan Ryan1, Tom Marshall1
1Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Insights
This study examines how cholesterol levels and cardiovascular disease (CVD) risk influence statin prescription for primary prevention. It investigates whether patients receive statins based on risk scores or cholesterol levels alone.
Area of Science:
- Cardiology
- Public Health
- Health Services Research
Background:
- Cardiovascular disease (CVD) prevention guidelines emphasize risk scoring for statin initiation.
- Evidence suggests statins are sometimes prescribed based on cholesterol levels rather than calculated CVD risk.
- Understanding prescribing patterns is crucial for effective primary prevention strategies.
Purpose of the Study:
- To investigate the independent influence of lipid levels and CVD risk scores on statin prescribing for primary CVD prevention in UK primary care.
- To determine if current statin prescribing aligns with established CVD risk assessment guidelines.
- To identify factors influencing statin prescription decisions.
Main Methods:
- Utilizing The Health Improvement Network (THIN) database of UK primary care electronic patient records.
- Creating a historical cohort of patients without prior CVD, not on statins, with measured lipid profiles.
- Calculating QRISK2 scores and analyzing subsequent statin prescription within 60 days using logistic regression.
Main Results:
- Analysis will determine the predictive power of cholesterol levels versus QRISK2 scores on statin prescription.
- Descriptive statistics will reveal trends in statin prescribing practices.
- Secondary analysis will explore other influencing factors and inter-prescriber variability.
Conclusions:
- Findings will clarify the role of cholesterol and CVD risk in primary prevention statin decisions.
- The study aims to inform clinical practice and guideline adherence for CVD prevention.
- Results will contribute to optimizing statin prescribing for maximum public health benefit.
Introduction:
Risk scoring is an integral part of the prevention of cardiovascular disease (CVD) and should form the basis for the decision to offer medication to reduce cholesterol (statins). However, there is a suggestion in the literature that many patients are still initiated on statins based on raised cholesterol rather than a raised CVD risk. It is important, therefore, to investigate the role that lipid levels and CVD risks have in the decision to prescribe. This research will establish how cholesterol levels and CVD risk independently influence the prescribing of statins for the primary prevention of CVD in primary care.
Methods And Analysis:
The Health Improvement Network (THIN) is a database of coded primary care electronic patient records from over 500 UK general practices. From this resource, a historical cohort will be created of patients without a diagnosis of CVD, not currently receiving a prescription for statins and who had a lipid profile measured. A post hoc QRISK2 score will be calculated for these patients and they will be followed up for 60 days to establish whether they were subsequently prescribed a statin. Primary analysis will consist of predictive modelling using multivariate logistic regression with potential predictors including cholesterol level, calculated QRISK2 score, sociodemographic characteristic and comorbidities. Descriptive statistics will be used to identify trends in prescribing and further secondary analysis will explore what other factors may have influenced the prescribing of statins and the degree of interprescriber variability.
Ethics And Dissemination:
The THIN Data Collection Scheme was approved by the South-East Multicentre Research Ethics Committee in 2003. Individual studies using THIN require Scientific Review Committee approval. The original protocol for this study and a subsequent amendment have been approved (16THIN009A1). The results will be published in a peer review journal and presented at national and international conferences.
More Related Videos
03:05Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
Published on: November 21, 2025
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:27Coronary Artery Disease V: Interprofessional Care
01:29Cholesterol: Significance and Regulation
Considering cholesterol and...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT